(1 June 2022)
Overexpression of glutathione-S-transferase, MGSTII, confers resistance to busulfan and melphalan
Associated conditions: Code separately any associated extraintestinal manifestations (arthropathy, uveitis, erythema nodosum, PSC) when documented by the provider as related to Crohns disease
We need glutathione to move these toxic substances through the detoxification process and into elimination pathways via the kidneys, liver (bile), and intestines [4]
HIGHLIGHTS: Stable BPC-157, a novel anti-ulcer peptide (1) BPC-157: Healing in different tissues Tendon Healing (4) Bone healing BPC-157 & Neuroprotective effect Effect on Spinal Cord Injury Blood Pressure Tendon Healing (4) Bone healing Stable BPC-157 as anti-ulcer agent (1) Stable gastric pentadecapeptide BPC 157 is a novel anti-ulcer peptide, used in trials for the treatment of ulcerative colitis and now multiple sclerosis, lethal dose (dosage required to kill 1% of the test population, LD1) not reported
Retrieved June 3, 2026, from DrugBank Online